Interpace Biosciences, Inc.
(NASDAQ : IDXG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
IQVIQVIA Holdings, Inc. 1.81%170.660.0%$160.98m
DGXQuest Diagnostics, Inc. 0.34%123.244.2%$137.15m
LHLaboratory Corp. of America Holdings 1.13%198.872.4%$132.87m
SYNHSyneos Health, Inc. 3.32%64.700.0%$49.94m
NRCNational Research Corp. 1.65%50.000.0%$1.81m
AMEHApollo Medical Holdings, Inc. 2.09%18.050.0%$1.46m
BASIBioanalytical Systems, Inc. 0.57%7.100.2%$0.40m
PLXProtalix Biotherapeutics, Inc. -0.58%3.4625.3%$0.38m
IDXGInterpace Biosciences, Inc. 0.63%3.1822.8%$0.25m
PMDPsychemedics Corp. 9.15%4.950.7%$0.15m

Company Profile

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.